The Predictive Value of Coronary Artery Calcium Score - Trial NCT06311071
Access comprehensive clinical trial information for NCT06311071 through Pure Global AI's free database. This phase not specified trial is sponsored by Shiraz University of Medical Sciences and is currently Completed. The study focuses on Coronary Artery Disease. Target enrollment is 498 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shiraz University of Medical Sciences
Timeline & Enrollment
N/A
Jan 01, 2022
Sep 01, 2023
Primary Outcome
coronary artery disease,coronary calcium score
Summary
In this analytical prospective study 498 patients over 40 years with any cardiovascular
 symptoms and without pre-established coronary artery disease ( CAD) were enrolled. Patients
 underwent CT scans to measure coronary artery calcium score (CACS), and total calcium scores
 were recorded. Then, conventional coronary angiography was performed for all the participants
 as the gold standard for diagnosing CAD (defined as at least one stenotic coronary artery
 with ≥ 50%). Framingham risk score (FRS) was also estimated for all the patients
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06311071
Non-Device Trial